Premium
Erratum: Activity and Tolerability of Nilotinib: A Retrospective Multicenter Analysis of Chronic Myeloid Leukemia Patients Who Are Imatinib Resistant or Intolerant
Author(s) -
KorenMichowitz Maya,
le Coutre Philipp,
Duyster Justus,
Scheid Christof,
Panayiotidis Panayiotis,
Prejzner Witold,
Rowe Jacob M.,
Schwarz Michaela,
Goldschmidt Neta,
Nagler Ar
Publication year - 2010
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.25569
Subject(s) - nilotinib , imatinib , medicine , protein kinase domain , myeloid leukemia , pdgfra , oncology , imatinib mesylate , genetics , biology , stromal cell , gist , gene , mutant